C.R. Jackson

Biotech, healthcare, value, research analyst
C.R. Jackson
Biotech, healthcare, value, research analyst
Contributor since: 2012
NuPathe Takes Investors Down A Bumpy Road
Is Biodel A Buy Or Sell?
How High Will Bluebird Bio Fly?
Will Coronado Biosciences Revolutionize Medicine?
What Is On The Horizon For XOMA?
Can Cempra Beat The Superbugs?
Is It Time To Give Up On Dendreon?
Why Did Pain Therapeutics Increase Over 25%?